Jan. 10 (UPI) — Scientists have developed a single dose treatment that has shown promise for combating all forms of the Ebola virus, a study says.
The new medication successfully blocked a strain of the deadly virus in nonhuman primates and ferrets, according to a study published Thursday in the journal Cell Host & Microbe.
The drug, a two-antibody combination called MBP134, was successful against several strains of Ebola, including the Zaire strain behind the current months-long outbreak in the Democratic Republic of Congo.
Read more
Comments are closed.